The Promise and Harms of Screening for Plasma Cell Dyscrasias.
BRITISH JOURNAL OF HAEMATOLOGY(2023)
摘要
In this perspective, we highlight both the promise and harms of screening for plasma cell dyscrasias, as well as the implications of the use of mass spectrometry for diagnosing monoclonal gammopathy of undetermined significance in routine practice.
更多查看译文
关键词
Diagnosis Criteria
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要